Skip to content
Disclosery

Boxer Capital, LLC

Follow

13F filer, CIK 1465837, San Diego, CA

Boxer Capital, LLC reported $2,006,361,800 across 52 holdings for the quarter ended 2023-12-31, in a 13F-HR filed 2024-02-14. Its ten largest share positions make up 57.08% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000895345-24-000061

Period
2023-12-31
Reported value
$2.01B
Holdings
52
Top 10 weight
57.08%
New
4
Sold out
25

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ARGXadded+75,000$28.5M
ARVNnew+608,614$25.1M
GPCRnew+400,000$16.3M
TNGXadded+1,075,000$10.6M
IMVTadded+250,000$10.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
AMLXexited-2,084,000-$38.2M
XBIexited-500,000-$36.5M
VTYXexited-850,000-$29.5M
FOLDexited-2,325,000-$28.3M
EXELexited-1,150,000-$25.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2023

Share positions as resolved from 13F-HR 0000895345-24-000061, largest first. % of portfolio is the value over $2,006,361,800, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MIRATI THERAPEUTICS INCMIRATI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,000,000 shares; 2023Q2: 2,000,000 shares; 2023Q3: 3,201,440 shares; 2023Q4: 3,201,440 shares 3,201,440$188M9.37%0
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,100,000 shares; 2023Q2: 2,100,000 shares; 2023Q3: 2,100,000 shares; 2023Q4: 2,100,000 shares 2,100,000$175M8.74%0Timeline
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 3,421,541 shares; 2023Q2: 3,421,541 shares; 2023Q3: 3,421,541 shares; 2023Q4: 3,421,541 shares 3,421,541$125M6.22%0
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 4,684,264 shares; 2023Q2: 4,684,264 shares; 2023Q3: 4,684,264 shares; 2023Q4: 4,279,464 shares 4,279,464$123M6.12%-404,800Timeline
APLSAPELLIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,576,000 shares; 2023Q2: 1,576,000 shares; 2023Q3: 1,726,000 shares; 2023Q4: 1,726,000 shares 1,726,000$103M5.15%0Timeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 500,000 shares; 2023Q2: 500,000 shares; 2023Q3: 500,000 shares; 2023Q4: 500,000 shares 500,000$90.2M4.49%0Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 6,448,359 shares; 2023Q2: 6,448,359 shares; 2023Q3: 6,448,359 shares; 2023Q4: 6,448,359 shares 6,448,359$89.3M4.45%0Timeline
IMMUNOGEN INCIMMUNOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 2,961,000 shares; 2023Q3: 2,961,000 shares; 2023Q4: 2,961,000 shares 2,961,000$87.8M4.38%0
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,210,192 shares; 2023Q2: 1,210,192 shares; 2023Q3: 1,210,192 shares; 2023Q4: 1,120,192 shares 1,120,192$82.4M4.11%-90,000Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 7,123,642 shares; 2023Q2: 7,123,642 shares; 2023Q3: 7,123,642 shares; 2023Q4: 8,198,642 shares 8,198,642$81.2M4.05%+1,075,000Timeline
KARUNA THERAPEUTICS INCKARUNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 250,000 shares; 2023Q3: 250,000 shares; 2023Q4: 250,000 shares 250,000$79.1M3.94%0
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,202,812 shares; 2023Q2: 2,202,812 shares; 2023Q3: 2,202,812 shares; 2023Q4: 2,202,812 shares 2,202,812$78.4M3.91%0Timeline
SRPTSAREPTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 775,000 shares; 2023Q2: 600,000 shares; 2023Q3: 600,000 shares; 2023Q4: 650,000 shares 650,000$62.7M3.12%+50,000Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 75,000 shares; 2023Q3: 85,000 shares; 2023Q4: 160,000 shares 160,000$60.9M3.03%+75,000Timeline
MERUS N VMERUS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,900,000 shares; 2023Q2: 1,900,000 shares; 2023Q3: 1,900,000 shares; 2023Q4: 1,900,000 shares 1,900,000$52.2M2.6%0
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,466,051 shares; 2023Q2: 1,466,051 shares; 2023Q3: 1,466,051 shares; 2023Q4: 1,466,051 shares 1,466,051$43.9M2.19%0Timeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 750,000 shares; 2023Q4: 1,000,000 shares 1,000,000$42.1M2.1%+250,000Timeline
AKROAKERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 831,495 shares; 2023Q2: 1,676,733 shares; 2023Q3: 1,676,733 shares; 2023Q4: 1,676,733 shares 1,676,733$39.2M1.95%0Timeline
LEGNLEGEND BIOTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 600,000 shares; 2023Q3: 600,000 shares; 2023Q4: 600,000 shares 600,000$36.1M1.8%0Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 400,000 shares; 2023Q2: 400,000 shares; 2023Q3: 400,000 shares; 2023Q4: 400,000 shares 400,000$31.8M1.59%0Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,432,200 shares; 2023Q2: 1,602,200 shares; 2023Q3: 1,602,200 shares; 2023Q4: 1,602,200 shares 1,602,200$30.6M1.53%0Timeline
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,300,000 shares; 2023Q2: 1,300,000 shares; 2023Q3: 1,300,000 shares; 2023Q4: 1,300,000 shares 1,300,000$27.8M1.39%0Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 600,000 shares; 2023Q2: 600,000 shares; 2023Q3: 600,000 shares; 2023Q4: 600,000 shares 600,000$27.6M1.38%0Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 608,614 shares 608,614$25.1M1.25%newTimeline
PRTAPROTHENA CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 300,000 shares; 2023Q2: 300,000 shares; 2023Q3: 625,000 shares; 2023Q4: 665,000 shares 665,000$24.2M1.2%+40,000Timeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,650,000 shares; 2023Q2: 1,650,000 shares; 2023Q3: 1,650,000 shares; 2023Q4: 1,650,000 shares 1,650,000$20.2M1.01%0Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,169,132 shares; 2023Q2: 1,819,132 shares; 2023Q3: 1,819,132 shares; 2023Q4: 1,819,132 shares 1,819,132$20M1%0Timeline
ITEOS THERAPEUTICS INCITEOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,154,058 shares; 2023Q2: 2,154,058 shares; 2023Q3: 1,804,058 shares; 2023Q4: 1,804,058 shares 1,804,058$19.8M0.98%0
DAWNDAY ONE BIOPHARMACEUTICALS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,189,943 shares; 2023Q2: 1,189,943 shares; 2023Q3: 1,189,943 shares; 2023Q4: 1,189,943 shares 1,189,943$17.4M0.87%0Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 400,000 shares 400,000$16.3M0.81%newTimeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,054,000 shares; 2023Q2: 1,732,571 shares; 2023Q3: 1,732,571 shares; 2023Q4: 1,732,571 shares 1,732,571$15.9M0.79%0Timeline
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 3,705,133 shares; 2023Q2: 3,705,133 shares; 2023Q3: 3,705,133 shares; 2023Q4: 1,400,000 shares 1,400,000$11.4M0.57%-2,305,133Timeline
PRLDPRELUDE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 699,047 shares; 2023Q2: 2,495,018 shares; 2023Q3: 2,495,018 shares; 2023Q4: 2,568,287 shares 2,568,287$11M0.55%+73,269Timeline
RNAMAVIDITY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,121,327 shares; 2023Q2: 1,121,327 shares; 2023Q3: 1,121,327 shares; 2023Q4: 1,121,327 shares 1,121,327$10.1M0.51%0Timeline
NKTXNKARTA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 1,440,000 shares 1,440,000$9.5M0.47%newTimeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 710,644 shares; 2023Q2: 710,644 shares; 2023Q3: 646,058 shares; 2023Q4: 646,058 shares 646,058$8.94M0.45%0Timeline
THRDTHIRD HARMONIC BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 570,417 shares; 2023Q2: 570,417 shares; 2023Q3: 520,417 shares; 2023Q4: 750,000 shares 750,000$8.23M0.41%+229,583Timeline
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 450,000 shares; 2023Q3: 450,000 shares; 2023Q4: 450,000 shares 450,000$6.82M0.34%0Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 3,000,000 shares; 2023Q3: 3,000,000 shares; 2023Q4: 3,000,000 shares 3,000,000$6.33M0.32%0Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 250,000 shares 250,000$5.38M0.27%newTimeline
OBIOORCHESTRA BIOMED HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 250,000 shares; 2023Q2: 250,000 shares; 2023Q3: 238,193 shares; 2023Q4: 238,193 shares 238,193$2.17M0.11%0Timeline
FATEFATE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 500,000 shares; 2023Q2: 500,000 shares; 2023Q3: 500,000 shares; 2023Q4: 500,000 shares 500,000$1.87M0.09%0Timeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 600,000 shares; 2023Q4: 600,000 shares 600,000$1.82M0.09%0Timeline
BCABBIOATLA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 686,347 shares; 2023Q2: 686,347 shares; 2023Q3: 686,347 shares; 2023Q4: 686,347 shares 686,347$1.69M0.08%0Timeline
BDTXBLACK DIAMOND THERAPEUTICS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,014,858 shares; 2023Q2: 2,014,858 shares; 2023Q3: 506,000 shares; 2023Q4: 506,000 shares 506,000$1.42M0.07%0Timeline
RAIN ONCOLOGY INCRAIN ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,147,212 shares; 2023Q2: 1,152,212 shares; 2023Q3: 1,152,212 shares; 2023Q4: 1,152,212 shares 1,152,212$1.38M0.07%0
MISTMILESTONE PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 698,861 shares; 2023Q2: 698,861 shares; 2023Q3: 309,007 shares; 2023Q4: 309,007 shares 309,007$516K0.03%0Timeline
DBV TECHNOLOGIES S ADBV TECHNOLOGIES S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,450,000 shares; 2023Q2: 1,450,000 shares; 2023Q3: 985,100 shares; 2023Q4: 500,000 shares 500,000$476K0.02%-485,100
TARAPROTARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 209,227 shares; 2023Q2: 209,227 shares; 2023Q3: 209,227 shares; 2023Q4: 209,227 shares 209,227$392K0.02%0Timeline
ATRECA INCATRECA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,202,333 shares; 2023Q2: 2,202,333 shares; 2023Q3: 2,202,333 shares; 2023Q4: 2,202,333 shares 2,202,333$291K0.01%0
NUVATION BIO INCNUVATION BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 266,666 shares; 2023Q2: 266,666 shares; 2023Q3: 266,666 shares; 2023Q4: 266,666 shares 266,666$16K<0.01%0
SRZNWSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 66,666 shares; 2023Q2: 66,666 shares; 2023Q3: 66,666 shares; 2023Q4: 66,666 shares 66,666$1.33K<0.01%0Timeline

Sold out in Q4 2023

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
AMLXAMYLYX PHARMACEUTICALS INC2,084,000$38.2Mshares
XBISPDR SERIES TRUST500,000$36.5Mshares
VTYXVENTYX BIOSCIENCES INC850,000$29.5Mshares
FOLDAMICUS THERAPEUTIC2,325,000$28.3Mshares
EXELEXELIXIS INC1,150,000$25.1Mshares
SAGE THERAPEUTICS INCSAGE THERAPEUTICS INC1,094,000$22.5Mshares
VKTXVIKING THERAPEUTICS INC2,000,000$22.1Mshares
PMVPPMV PHARMACEUTICALS INC3,163,795$19.4Mshares
POINT BIOPHARMA GLOBAL INCPOINT BIOPHARMA GLOBAL INC2,500,000$16.7Mshares
MDGLMADRIGAL PHARMACEUTICALS INC100,000$14.6Mshares
CGEMCULLINAN THERAPEUTICS INC1,074,082$9.72Mshares
NRIXNURIX THERAPEUTICS INC1,224,892$9.63Mshares
ABOSACUMEN PHARMACEUTICALS INC2,206,983$9.16Mshares
ASNDASCENDIS PHARMA A/S95,000$8.9Mshares
GOSSGOSSAMER BIO INC6,497,700$5.41Mshares
COGTCOGENT BIOSCIENCES INC525,000$5.12Mshares
CNTACENTESSA PHARMACEUTICALS PLC770,708$4.99Mshares
RAPT THERAPEUTICS INCRAPT THERAPEUTICS INC300,000$4.99Mshares
Mersana Therapeutics IncMersana Therapeutics Inc2,000,000$2.54Mshares
EQRX INCEQRX INC1,000,000$2.22Mshares
2SEVENTY BIO INC COMMON STO…2SEVENTY BIO INC COMMON STOCK459,836$1.8Mshares
VERRICA PHARMACEUTICALS INCVERRICA PHARMACEUTICALS INC166,955$649Kshares
NGM BIOPHARMACEUTICALS INCNGM BIOPHARMACEUTICALS INC500,000$535Kshares
THESEUS PHARMACEUTICALS INCTHESEUS PHARMACEUTICALS INC150,000$404Kshares
ZIOPHARM ONCOLOGY INCZIOPHARM ONCOLOGY INC1,100,000$145Kshares

How Q4 2023 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000895345-24-000061 base2024-02-14acceptance time not in the bulk data set